Your browser doesn't support javascript.
loading
Eif2b3 mutants recapitulate phenotypes of vanishing white matter disease and validate novel disease alleles in zebrafish.
Lee, Yu-Ri; Kim, Se Hee; Ben-Mahmoud, Afif; Kim, Oc-Hee; Choi, Tae-Ik; Lee, Kang-Han; Ku, Bonsu; Eum, Juneyong; Kee, Yun; Lee, Sangkyu; Cha, Jihoon; Won, DongJu; Lee, Seung-Tae; Choi, Jong Rak; Lee, Joon Soo; Kim, Heung Dong; Kim, Hyung-Goo; Bonkowsky, Joshua L; Kang, Hoon-Chul; Kim, Cheol-Hee.
Afiliação
  • Lee YR; Department of Biology, Chungnam National University, Daejeon, Korea.
  • Kim SH; Department of Pediatrics, Division of Pediatric Neurology, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Yonsei University College of Medicine, Severance Children's Hospital, Seoul, Korea.
  • Ben-Mahmoud A; Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
  • Kim OH; Department of Biology, Chungnam National University, Daejeon, Korea.
  • Choi TI; Department of Biology, Chungnam National University, Daejeon, Korea.
  • Lee KH; Department of Biology, Chungnam National University, Daejeon, Korea.
  • Ku B; Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.
  • Eum J; Division of Biomedical Convergence, Kangwon National University, Chuncheon, Korea.
  • Kee Y; Division of Biomedical Convergence, Kangwon National University, Chuncheon, Korea.
  • Lee S; College of Pharmacy, Kyungpook National University, Daegu, Korea.
  • Cha J; Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Won D; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Lee ST; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Choi JR; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Lee JS; Department of Pediatrics, Division of Pediatric Neurology, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Yonsei University College of Medicine, Severance Children's Hospital, Seoul, Korea.
  • Kim HD; Department of Pediatrics, Division of Pediatric Neurology, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Yonsei University College of Medicine, Severance Children's Hospital, Seoul, Korea.
  • Kim HG; Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
  • Bonkowsky JL; Department of Pediatrics, University of Utah School of Medicine and Brain and Spine Center, Primary Children's Hospital, Salt Lake City, UT, USA.
  • Kang HC; Department of Pediatrics, Division of Pediatric Neurology, Pediatric Epilepsy Clinic, Epilepsy Research Institute, Yonsei University College of Medicine, Severance Children's Hospital, Seoul, Korea.
  • Kim CH; Department of Biology, Chungnam National University, Daejeon, Korea.
Hum Mol Genet ; 30(5): 331-342, 2021 04 27.
Article em En | MEDLINE | ID: mdl-33517449
ABSTRACT
Leukodystrophy with vanishing white matter (VWM), also called Childhood Ataxia with Central Nervous System Hypomyelination, is caused by mutations in the subunits of the eukaryotic translation initiation factor, EIF2B1, EIF2B2, EIF2B3, EIF2B4 or EIF2B5. However, little is known regarding the underlying pathogenetic mechanisms, and there is no curative treatment for VWM. In this study, we established the first EIF2B3 animal model for VWM disease in vertebrates by CRISPR mutagenesis of the highly conserved zebrafish ortholog eif2b3. Using CRISPR, we generated two mutant alleles in zebrafish eif2b3, 10- and 16-bp deletions, respectively. The eif2b3 mutants showed defects in myelin development and glial cell differentiation, and increased expression of genes in the induced stress response pathway. Interestingly, we also found ectopic angiogenesis and increased VEGF expression. Ectopic angiogenesis in the eif2b3 mutants was reduced by the administration of VEGF receptor inhibitor SU5416. Using the eif2b3 mutant zebrafish model together with in silico protein modeling analysis, we demonstrated the pathogenicity of 18 reported mutations in EIF2B3, as well as of a novel variant identified in a 19-month-old female patient c.503 T > C (p.Leu168Pro). In summary, our zebrafish mutant model of eif2b3 provides novel insights into VWM pathogenesis and offers rapid functional analysis of human EIF2B3 gene variants.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peixe-Zebra / Regulação da Expressão Gênica no Desenvolvimento / Neovascularização Fisiológica / Fator de Iniciação 2B em Eucariotos / Leucoencefalopatias / Bainha de Mielina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Infant Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peixe-Zebra / Regulação da Expressão Gênica no Desenvolvimento / Neovascularização Fisiológica / Fator de Iniciação 2B em Eucariotos / Leucoencefalopatias / Bainha de Mielina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Infant Idioma: En Ano de publicação: 2021 Tipo de documento: Article